183 related articles for article (PubMed ID: 18953536)
1. Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo.
Wurzenberger C; Koelzer VH; Schreiber S; Anz D; Vollmar AM; Schnurr M; Endres S; Bourquin C
Cancer Immunol Immunother; 2009 Jun; 58(6):901-13. PubMed ID: 18953536
[TBL] [Abstract][Full Text] [Related]
2. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets.
Kastenmüller K; Wille-Reece U; Lindsay RW; Trager LR; Darrah PA; Flynn BJ; Becker MR; Udey MC; Clausen BE; Igyarto BZ; Kaplan DH; Kastenmüller W; Germain RN; Seder RA
J Clin Invest; 2011 May; 121(5):1782-96. PubMed ID: 21540549
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
4. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
5. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo.
Brunner C; Seiderer J; Schlamp A; Bidlingmaier M; Eigler A; Haimerl W; Lehr HA; Krieg AM; Hartmann G; Endres S
J Immunol; 2000 Dec; 165(11):6278-86. PubMed ID: 11086063
[TBL] [Abstract][Full Text] [Related]
6. Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer.
Hong X; Dong T; Hu J; Yi T; Li W; Zhang Z; Lin S; Niu W
Int J Colorectal Dis; 2013 Jan; 28(1):25-33. PubMed ID: 22777000
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo.
Warger T; Osterloh P; Rechtsteiner G; Fassbender M; Heib V; Schmid B; Schmitt E; Schild H; Radsak MP
Blood; 2006 Jul; 108(2):544-50. PubMed ID: 16537810
[TBL] [Abstract][Full Text] [Related]
8. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype.
Flohé SB; Brüggemann J; Lendemans S; Nikulina M; Meierhoff G; Flohé S; Kolb H
J Immunol; 2003 Mar; 170(5):2340-8. PubMed ID: 12594256
[TBL] [Abstract][Full Text] [Related]
9. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
[TBL] [Abstract][Full Text] [Related]
10. Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand.
Rizzitelli A; Vremec D; Villadangos JA; Mavaddat N; Wright MD; Shortman K
Eur J Immunol; 2005 Nov; 35(11):3209-20. PubMed ID: 16224811
[TBL] [Abstract][Full Text] [Related]
11. Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist.
Jung ID; Jeong SK; Lee CM; Noh KT; Heo DR; Shin YK; Yun CH; Koh WJ; Akira S; Whang J; Kim HJ; Park WS; Shin SJ; Park YM
Cancer Res; 2011 Apr; 71(8):2858-70. PubMed ID: 21368092
[TBL] [Abstract][Full Text] [Related]
12. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection.
Morelli AE; O'Connell PJ; Khanna A; Logar AJ; Lu L; Thomson AW
Transplantation; 2000 Jun; 69(12):2647-57. PubMed ID: 10910289
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
[TBL] [Abstract][Full Text] [Related]
14. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cells from human lung cancer draining lymph nodes induce Tc1 responses.
Faith A; Peek E; McDonald J; Urry Z; Richards DF; Tan C; Santis G; Hawrylowicz C
Am J Respir Cell Mol Biol; 2007 Mar; 36(3):360-7. PubMed ID: 17023687
[TBL] [Abstract][Full Text] [Related]
16. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.
Wille-Reece U; Wu CY; Flynn BJ; Kedl RM; Seder RA
J Immunol; 2005 Jun; 174(12):7676-83. PubMed ID: 15944268
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
18. Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG.
Hubert FX; Voisine C; Louvet C; Heslan M; Josien R
J Immunol; 2004 Jun; 172(12):7485-94. PubMed ID: 15187127
[TBL] [Abstract][Full Text] [Related]
19. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]